A Systematic Review of Diagnostic Tests for Small Intestinal Bacterial Overgrowth
The DOI matches its Crossref record; 89 of the 89 references it cites were found in a registry or an index.
Abstract
Background A growing number of studies seem to suggest that small intestinal bacterial overgrowth (SIBO) is a common clinical problem. Although various techniques are available to make this diagnosis, tradition has accepted small bowel aspirate (>10(5) cfu/ml) as a gold standard. In this systematic review, the validity of culture and other diagnostic testing for SIBO is evaluated.Methods We performed a systematic review of the literature from 1966 to present using electronic databases (PubMed and OVID). Full paper review of those abstracts that fulfilled preset criteria was carried out to evaluate the validity of various tests in diagnosing SIBO. Finally, all papers were evaluated against published standards for studies on diagnostic testing.Results Seventy-one papers met the criteria for detailed review. Studies were very heterogeneous with regards to patient populations, test definitions, sample size, and methods in general. Small bowel colony counts appeared elevated in most gastrointestinal diseases compared to controls. The traditional definition of >10(5) cfu/ml was usually indicative of stagnant loop conditions. Although, numerous diagnostic tests were studied, not even culture papers met the quality standards described by Reid et al. Breath testing and other diagnostic testing suffered therefore from the lack of a gold standard against which to validate in addition to the poor quality.Conclusions There is no validated diagnostic test or gold standard for SIBO. In this context, the most practical method to evaluate SIBO in studies at this time would be a test, treat, and outcome technique.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“bacterial overgrowth is currently assessed clinically by analyzing microbes in samples of small bowel fluid aspirates obtained by endoscopy (58).”
From Contributions of microbiome and mechanical deformation to intestinal bacterial overgrowth and inflammation in a human gut-on-a-chip (2016) · cites this paper as [58]
In the citing paper
“Breath tests are not validated to accurately detect small intestinal bacterial overgrowth.”
From Intestinal microbiota in functional bowel disorders: a Rome foundation report (2013) · cites this paper as [91]
In the citing paper
“Even the validity of the ‘gold standard’, jejunal cultures >105 cfu/ml with colonic-type bacteria, has been challenged, largely because this cut-off was established from samples following surgical diversion.91”
From Intestinal microbiota in functional bowel disorders: a Rome foundation report (2013) · cites this paper as [91]
In the citing paper
“The role of SIBO in the pathogenesis of IBS is very controversial because the breath tests employed to establish this role have not been validated.90 91”
From Intestinal microbiota in functional bowel disorders: a Rome foundation report (2013) · cites this paper as [91]
Citations
Cites
(2012) · Hepatogastroenterology · doi:10.5754/hge12458 · Cited by 1,977
(2008) · Wiley eBooks · doi:10.1002/9781444303254 · Cited by 1,366
Eradication of Small Intestinal Bacterial Overgrowth Reduces Symptoms of Irritable Bowel Syndrome
Pimentel, M., Chow, E. J., & Lin, H. C. (2000) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2000.03368.x · Cited by 780
Self-citationUse of methodological standards in diagnostic test research. Getting better but still not good
Reid, M. C. (1995) · JAMA · doi:10.1001/jama.274.8.645 · Cited by 712 · cited 4×
“[14] Dig Dis Sci (2008) 53:1443–1454 1445”
BackgroundMethodInfluentialPimentel, M. (2003) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(02)05902-6 · Cited by 669
Self-citationSmall intestinal bacterial overgrowth in patients with irritable bowel syndrome
Posserud, I., Stotzer, P.-O., Björnsson, E. S., Abrahamsson, H., & Simrén, M. (2007) · Gut · doi:10.1136/gut.2006.108712 · Cited by 499 · cited 9×
“found only 12% of their control population with C5 9 10(3) cfu/ml bacteria when cultured [52].”
BackgroundInfluentialPimentel, M., Park, S., Mirocha, J., Kane, S. V., & Kong, Y. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-145-8-200610170-00004 · Cited by 466
Self-citationThe diagnosis of small bowel bacterial overgrowth
Corazza, G. R., Menozzi, M. G., Strocchi, A., Rasciti, L., Vaira, D., Lecchini, R., Avanzini, P., Chezzi, C., & Gasbarrini, G. (1990) · Gastroenterology · doi:10.1016/0016-5085(90)90818-l · Cited by 352
Small Intestine Bacterial Overgrowth
King, C. E., & Toskes, P. P. (1979) · Gastroenterology · doi:10.1016/s0016-5085(79)91337-4 · Cited by 346
Sharara, A. I., Aoun, E., Abdul-Baki, H., Mounzer, R., Sidani, S., & ElHajj, I. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00458.x · Cited by 344
Research works printed but not linked: 3
- Hamilton JD, Dyer NH, Dawson AM, O’Grady FW, Vince A, Fenton JC, Mollin DL (1970) Assessment and significance of bacterial overgrowth in the small bowel. Q J Med 39(154):265–285
- Farivar S, Fromm H, Schindler D, Schmidt FW (1979) Sensitivity of bile acid breath test in the diagnosis of bacterial overgrowth in the small intestine with and without the stagnant (blind) loop syndrome. Dig Dis Sci 24(1):33–40 · DOI
- Tillman RKC, Toskes P (1981) Continued experience with the xylose breath test: evidence that the small bowel culture as the gold standard for bacterial overgrowth may be tarnished. Gastroenterology 80:A1304
Cited by
Intestinal microbiota in functional bowel disorders: a Rome foundation report
Simrén, M., Barbara, G., Flint, H. J., Spiegel, B. M. R., Spiller, R. C., Vanner, S., Verdu, E. F., Whorwell, P. J., & Zoetendal, E. G. (2013) · Gut · doi:10.1136/gutjnl-2012-302167 · Cited by 939
“91 Even the validity of the ‘gold standard’, jejunal cultures >10(5) cfu/ml with colonic-type bacteria, has been challenged, largely because this cut-off was established from samples following surgical diversion.(91) Studies in IBS patients showed relatively few bacteria in the duodenum and proximal jejunum and no obv…”
BackgroundKim, H. J., Li, H., Collins, J. J., & Ingber, D. E. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1522193112 · Cited by 922
Rezaie, A., Buresi, M., Lembo, A., Lin, H., McCallum, R., Rao, S., Schmulson, M., Valdovinos, M., Zakko, S., & Pimentel, M. (2017) · American Journal of Gastroenterology · doi:10.1038/ajg.2017.46 · Cited by 852
Self-citationSmall intestinal bacterial overgrowth syndrome
Bures, J. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i24.2978 · Cited by 620
The gastrointestinal microbiota as a site for the biotransformation of drugs
Sousa, T., Paterson, R., Moore, V., Carlsson, A., Abrahamsson, B., & Basit, A. W. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.07.009 · Cited by 618
ACG Clinical Guideline: Small Intestinal Bacterial Overgrowth
Pimentel, M., Saad, R. J., Long, M. D., & Rao, S. S. C. (2020) · American Journal of Gastroenterology · doi:10.14309/ajg.0000000000000501 · Cited by 502
“Healthy controls have , 10 3 CFU/mL in the small bowel, and concentrations above 10 5 CFU are almost exclusively seen in patients with gastrectomy (14).”
BackgroundMethodInfluentialSelf-citationCurrent Sampling Methods for Gut Microbiota: A Call for More Precise Devices
Tang, Q., Jin, G., Wang, G., Liu, T., Liu, X., Wang, B., & Cao, H. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00151 · Cited by 455
“The aspiration and culture of small intestinal fluid are usually supposed to be the gold standard for the diagnosis of small intestinal bacterial overgrowth, which is defined as ≥ 105 colony-forming units per milliliter (CFU/mL) upon the culture of aspirated fluid (Khoshini et al., 2008; Grace et al., 2013; Erdogan et…”
Background(2009) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2009.03951.x · Cited by 444
Kastl, A. J., Terry, N. A., Wu, G. D., & Albenberg, L. G. (2020) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2019.07.006 · Cited by 358
Proton Pump Inhibitor Use and the Risk of Small Intestinal Bacterial Overgrowth: A Meta-analysis
Lo, W., & Chan, W. W. (2013) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2012.12.011 · Cited by 353
The role of small intestinal bacterial overgrowth in Parkinson's disease
Fasano, A., Bove, F., Gabrielli, M., Petracca, M., Zocco, M. A., Ragazzoni, E., Barbaro, F., Piano, C., Fortuna, S., Tortora, A., et al. (2013) · Movement Disorders · doi:10.1002/mds.25522 · Cited by 344
“However, because the poorly absorbed disaccharide lactulose reaches the cecum, the LBT can be used to assess SIBO in the distal small bowel.(19) Therefore, we performed both tests to achieve higher diagnostic accuracy.”
MethodThe intestinal microbiota and chronic disorders of the gut
DuPont, A. W., & DuPont, H. L. (2011) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2011.133 · Cited by 307
“These researchers suggest that clinical illness (for example, abdominal bloating), response to antimicrobial treatment, and small intestinal bacterial count are the best methods to assess and diagnose SIBO”
Diagnosis and management of toxicities of immune checkpoint inhibitors in hepatocellular carcinoma
Sangro, B., Chan, S. L., Meyer, T., Reig, M., El-Khoueiry, A., & Galle, P. R. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2019.10.021 · Cited by 293
Contributions of the microbial hydrogen economy to colonic homeostasis
Carbonero, F., Benefiel, A. C., & Gaskins, H. R. (2012) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2012.85 · Cited by 293
Gut microbiota and gastrointestinal health: current concepts and future directions
Aziz, Q., Doré, J., Emmanuel, A., Guarner, F., & Quigley, E. M. M. (2013) · Neurogastroenterology & Motility · doi:10.1111/nmo.12046 · Cited by 280
Gatta, L., & Scarpignato, C. (2017) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13928 · Cited by 266
Small intestinal bacterial overgrowth in Parkinson's disease
Tan, A. H., Mahadeva, S., Thalha, A. M., Gibson, P. R., Kiew, C. K., Yeat, C. M., Ng, S. W., Ang, S. P., Chow, S. K., Tan, C. T., et al. (2014) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2014.02.019 · Cited by 274
“As the prevalence of non-hydrogen producers was reported to be only around 2e20% [16,19,20], a possible explanation is that some of these patients might have had a prolonged oro-cecal transit time (OCTT) (in line with the findings of the two studies that have investigated this issue in PD) [5,6].”
BackgroundResultBellot, P., Francés, R., & Such, J. (2013) · Liver International · doi:10.1111/liv.12021 · Cited by 254
“Intestinal bacterial overgrowth is a very heterogeneous syndrome characterized by an increased number and/or abnormal type of bacteria in the small bowel (14).”
BackgroundGuidance on the management of diarrhoea during cancer chemotherapy
Andreyev, J., Ross, P., Donnellan, C., Lennan, E., Leonard, P., Waters, C., Wedlake, L., Bridgewater, J., Glynne-Jones, R., Allum, W., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70006-3 · Cited by 257
AGA Clinical Practice Update on Small Intestinal Bacterial Overgrowth: Expert Review
Quigley, E. M. M., Murray, J. A., & Pimentel, M. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.06.090 · Cited by 220
Self-citationGrace, E., Shaw, C., Whelan, K., & Andreyev, H. J. N. (2013) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12456 · Cited by 213
“The most commonly cited definition is quantitative: 10(5) or more colony-forming units per millilitre (CFU/mL) of bacteria grown from a small intestinal aspirate.(1) However, many patients with a wide range of GI conditions and symptoms have increased bacterial counts in the small intestine compared with healthy contr…”
BackgroundMethodInfluentialShah, A., Talley, N. J., Jones, M., Kendall, B. J., Koloski, N., Walker, M. M., Morrison, M., & Holtmann, G. J. (2020) · American Journal of Gastroenterology · doi:10.14309/ajg.0000000000000504 · Cited by 200
Gastrointestinal bacterial overgrowth: pathogenesis and clinical significance
Sachdev, A. H., & Pimentel, M. (2013) · Therapeutic Advances in Chronic Disease · doi:10.1177/2040622313496126 · Cited by 187
“For instance, the prevalence of SIBO in IBS varies from 30 to 85% depending on the source used [Pimentel et al. 2000; Lin, 2004; Lupascu et al. 2005; Khoshini et al. 2008].”
BackgroundMethodInfluentialSelf-citationHammer, H. F., Fox, M. R., Keller, J., Salvatore, S., Basilisco, G., Hammer, J., Lopetuso, L., Benninga, M., Borrelli, O., Dumitrascu, D., et al. (2022) · United European Gastroenterology Journal · doi:10.1002/ueg2.12133 · Cited by 189
Jacobs, C., Coss Adame, E., Attaluri, A., Valestin, J., & Rao, S. S. C. (2013) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12304 · Cited by 177
Breath Testing for Small Intestinal Bacterial Overgrowth: Maximizing Test Accuracy
Saad, R. J., & Chey, W. D. (2014) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2013.09.055 · Cited by 166
“However, small bowel culturing methodology is variable as reported in a systematic review of 50published studies from1996 to2007.(35) Considerable heterogeneity exists in methodology including: device placement for fluid aspiration, location and quantity of the aspirate, technique in sample handing and culture, and in…”
MethodSmall intestinal bacterial overgrowth: duodenal aspiration vs glucose breath test
Erdogan, A., Rao, S. S. C., Gulley, D., Jacobs, C., Lee, Y. Y., & Badger, C. (2015) · Neurogastroenterology & Motility · doi:10.1111/nmo.12516 · Cited by 164
How to Test and Treat Small Intestinal Bacterial Overgrowth: an Evidence-Based Approach
Rezaie, A., Pimentel, M., & Rao, S. S. (2016) · Current Gastroenterology Reports · doi:10.1007/s11894-015-0482-9 · Cited by 161
Self-citationSmall Intestinal Bacterial Overgrowth Recurrence After Antibiotic Therapy
Lauritano, E. C., Gabrielli, M., Scarpellini, E., Lupascu, A., Novi, M., Sottili, S., Vitale, G., Cesario, V., Serricchio, M., Cammarota, G., et al. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2008.02030.x · Cited by 160
“However, this test is invasive, expensive, and extremely difficult to be performed in the clinical setting (9).”
BackgroundAbnormal Breath Testing in IBS: A Meta-Analysis
Shah, E. D., Basseri, R. J., Chong, K., & Pimentel, M. (2010) · Digestive Diseases and Sciences · doi:10.1007/s10620-010-1276-4 · Cited by 165
“ml) [11]. The threshold used in this study is now contested, since it was only validated based on typical findings in Billroth II patients [ 14 ].”
BackgroundMethodInfluentialSelf-citationZhong, C., Qu, C., Wang, B., Liang, S., & Zeng, B. (2017) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000000814 · Cited by 172
Villanueva-Millán, M. J., Leite, G., Wang, J., Morales, W., Parodi, G., Pimentel, M. L., Barlow, G. M., Mathur, R., Rezaie, A. R., Sanchez, M., et al. (2022) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000001997 · Cited by 173
Self-citationSmall intestinal bacterial overgrowth in systemic sclerosis
Marie, I., Ducrotte, P., Denis, P., Menard, J.-F., & Levesque, H. (2009) · Rheumatology · doi:10.1093/rheumatology/kep226 · Cited by 156
Specimen Collection, Transport, and Processing: Bacteriology
Baron, E. J. (2015) · Manual of Clinical Microbiology · doi:10.1128/9781555817381.ch18 · Cited by 159
The microbiota-gut-brain axis in functional gastrointestinal disorders
De Palma, G., Collins, S. M., & Bercik, P. (2014) · Gut Microbes · doi:10.4161/gmic.29417 · Cited by 157
Gut microbiota in alcoholic liver disease: Pathogenetic role and therapeutic perspectives
Malaguarnera, G., Giordano, M., Nunnari, G., Bertino, G., & Malaguarnera, M. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i44.16639 · Cited by 158
Psychobiotics and the gut–brain axis: in the pursuit of happiness
Foster, J., & Zhou, L. (. (2015) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s61997 · Cited by 132
“This is largely due to the fact that the etiology of the SIBO remains unclear and the clinical symptoms vary greatly from asymptomatic to many nonspecific symptoms such as bloating, flatulence, abdominal discomfort, diarrhea, and abdominal pain, many of which overlap with the symptoms of IBD.(89) In more severe cases,…”
Duseja, A., Acharya, S. K., Mehta, M., Chhabra, S., Shalimar, Rana, S., Das, A., Dattagupta, S., Dhiman, R. K., & Chawla, Y. K. (2019) · BMJ Open Gastroenterology · doi:10.1136/bmjgast-2019-000315 · Cited by 143
Engstler, A. J., Aumiller, T., Degen, C., Dürr, M., Weiss, E., Maier, I. B., Schattenberg, J. M., Jin, C. J., Sellmann, C., & Bergheim, I. (2016) · Gut · doi:10.1136/gutjnl-2014-308379 · Cited by 136
Clinical predictors of small intestinal bacterial overgrowth by duodenal aspirate culture
Choung, R. S., Ruff, K. C., Malhotra, A., Herrick, L., Locke, G. R., Harmsen, W. S., Zinsmeister, A. R., Talley, N. J., & Saito, Y. A. (2011) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2011.04625.x · Cited by 135
“Antibiotic (within last 3 months) (n = 672), n (% yes) 71 (13) 5 (8) 8 (15) 84 (13)”
Losurdo, G., Leandro, G., Ierardi, E., Perri, F., Barone, M., Principi, M., & Leo, A. D. (2019) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm19113 · Cited by 135
“38 However, a quantitative examination with a pooled analysis of such data was lacking until now.”
Influence of gut microbiota on the development and progression of nonalcoholic steatohepatitis
Ghetti, F. D. F., de Oliveira, D. G., de Oliveira, J. M., Ferreira, L. E. V. V. D. C., Cesar, D. E., & Moreira, A. P. B. (2017) · European Journal of Nutrition · doi:10.1007/s00394-017-1524-x · Cited by 130
“lated sensitivities and specificities ranging from 31 to 77 and 44 to 100%, respectively [65, 66], leading to high falsepositive rates [67].”
BackgroundThe duodenal microbiome is altered in small intestinal bacterial overgrowth
Leite, G., Morales, W., Weitsman, S., Celly, S., Parodi, G., Mathur, R., Barlow, G. M., Sedighi, R., Millan, M. J. V., Rezaie, A., et al. (2020) · PLOS ONE · doi:10.1371/journal.pone.0234906 · Cited by 116
Self-citationJohnson, M. E., Stringer, A., & Bobrovskaya, L. (2018) · NeuroToxicology · doi:10.1016/j.neuro.2018.02.013 · Cited by 122
Chen, B., Kim, J. J.-W., Zhang, Y., Du, L., & Dai, N. (2018) · Journal of Gastroenterology · doi:10.1007/s00535-018-1476-9 · Cited by 117
“02) was observed when a more stringent criterion of bacterial count [ 10(5) CFU/mL as a positive test was used, generally accepted to be diagnostic for SIBO [69].”
Shah, A., Morrison, M., Burger, D. C., Martin, N., Rich, J., Jones, M., Koloski, N. A., Walker, M. M., Talley, N. J., & Holtmann, G. (2019) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.15133 · Cited by 122
“This stems from the lack of a universally accepted and applied gold standard for diagnosis of SIBO.(12) Presence of >10(5) colony forming units per millilitre (cfu/ml) of colonic‐type bacteria in culture of jejunal aspirates is the traditionally accepted gold standard for diagnosis SIBO.”
BackgroundSmall Intestinal Bacterial Overgrowth
Adike, A., & DiBaise, J. K. (2017) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2017.09.008 · Cited by 125
Small Intestinal Bacterial Overgrowth and Other Intestinal Disorders
Ghoshal, U. C., & Ghoshal, U. (2017) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2016.09.008 · Cited by 139
The Role of Intestinal Bacteria Overgrowth in Obesity-Related Nonalcoholic Fatty Liver Disease
Ferolla, S. M., Armiliato, G. N. D. A., Couto, C. A., & Ferrari, T. C. A. (2014) · Nutrients · doi:10.3390/nu6125583 · Cited by 124
“No studies were carried out measuring hydrogen and methane in the breath to ensure that there were no false negatives due to the presence of gastrointestinal bacteria not producing hydrogen [55].”
BackgroundSmall Intestinal Bacterial Overgrowth
Quigley, E. M. M., & Abu-Shanab, A. (2010) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2010.07.007 · Cited by 128
Altered Gut Microbiome and Intestinal Pathology in Parkinson’s Disease
Chiang, H.-L., & Lin, C.-H. (2019) · Journal of Movement Disorders · doi:10.14802/jmd.18067 · Cited by 104
Ghoshal, U. C., Sachdeva, S., Ghoshal, U., Misra, A., Puri, A. S., Pratap, N., Shah, A., Rahman, M. M., Gwee, K. A., Tan, V. P. Y., et al. (2022) · Indian Journal of Gastroenterology · doi:10.1007/s12664-022-01292-x · Cited by 109
“In contrast to this milder clinical profile, features of nutrient malabsorption and deficiencies like steatorrhea, anemia, sarcopenia, edema of lower extremities, neuropathy, metabolic bone disease, or tetany may be seen in more severe cases like the ones associated with scleroderma, jejuno-colonic fistulae, CIPO, int…”
BackgroundSmall Intestinal Bacterial Overgrowth in Children: A State-Of-The-Art Review
Avelar Rodriguez, D., Ryan, P. M., Toro Monjaraz, E. M., Ramirez Mayans, J. A., & Quigley, E. M. (2019) · Frontiers in Pediatrics · doi:10.3389/fped.2019.00363 · Cited by 91
Defining Small Intestinal Bacterial Overgrowth by Culture and High Throughput Sequencing
Leite, G., Rezaie, A. R., Mathur, R., Barlow, G. M., Rashid, M. A., Hosseini, A., Wang, J., Parodi, G., Villanueva-Millán, M. J., Sanchez, M., et al. (2023) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2023.06.001 · Cited by 98
Self-citationPimentel, M., Mathur, R., & Chang, C. C.-C. (2013) · Current Gastroenterology Reports · doi:10.1007/s11894-013-0356-y · Cited by 98
“However, this methodology, now referred to as the lactulose hydrogen breath test, does have technical limitations and a documented failure to validate the procedure in normal individuals [27].”
MethodSelf-citationPinn, D. M., Aroniadis, O. C., & Brandt, L. J. (2015) · Neurogastroenterology & Motility · doi:10.1111/nmo.12479 · Cited by 91
Evaluating Breath Methane as a Diagnostic Test for Constipation-Predominant IBS
Hwang, L. J., Low, K., Khoshini, R., Melmed, G., Sahakian, A. B., Makhani, M. D., Pokkunuri, V. B., & Pimentel, M. (2009) · Digestive Diseases and Sciences · doi:10.1007/s10620-009-0778-4 · Cited by 96
Self-citationScarpellini, E., Giorgio, V., Gabrielli, M., Lauritano, E. C., Pantanella, A., Fundaro, C., & Gasbarrini, A. (2009) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2009.03.033 · Cited by 91
Small intestinal bacterial overgrowth (SIBO) in irritable bowel syndrome: Frequency and predictors
Sachdeva, S., Rawat, A. K., Reddy, R. S., & Puri, A. S. (2011) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2011.06654.x · Cited by 86
Small Intestinal Bacterial Overgrowth in Functional Dyspepsia: A Systematic Review and Meta-Analysis
Gurusamy, S. R., Shah, A., Talley, N. J., Koloski, N. A., Jones, M. P., Walker, M. M., Morrison, M., & Holtmann, G. (2021) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000001197 · Cited by 91
“Studies not reporting original data, manuscripts not published as full articles, those reporting onmixed populations of FGIDs with no separate data on FD, or those who did not use clinically validated methods to diagnose SIBO in FD were excluded (11).”
Srinath, A., Young, E., & Szigethy, E. (2014) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000170 · Cited by 83
Tansel, A., & Levinthal, D. J. (2023) · Clinical and Translational Gastroenterology · doi:10.14309/ctg.0000000000000567 · Cited by 89
“10(3) cfu/mL have been shown to be clinically relevant, and $10(5) cfu/mL was generally seen in patients with altered anatomy (3,5).”
Dong, Y., Sui, L., Yang, F., Ren, X., Xing, Y., & Xiu, Z. (2022) · Food Chemistry · doi:10.1016/j.foodchem.2022.133561 · Cited by 86
Low-FODMAP Diet for Treatment of Irritable Bowel Syndrome.
Magge, S., & Lembo, A. J. (2012) · Europe PMC (PubMed Central) · Cited by 147
Pimentel, M. (2016) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13437 · Cited by 75
“Lactulose breath test measures hydrogen gas concentration following ingestion of 10 g of lactulose, a fermentable non-absorbable sugar, dissolved in water.(37) Gut bacteria metabolise this substrate, and hydrogen gas is”
BackgroundSelf-citationClinical and Histologic Mimickers of Celiac Disease
Kamboj, A. K., & Oxentenko, A. S. (2017) · Clinical and Translational Gastroenterology · doi:10.1038/ctg.2017.41 · Cited by 80
“While no universal definition of SIBO exists, the gold standard remains a small bowel aspirate demonstrating 10(5) or more colony forming units per milliliter of bacteria grown.(19) The treatment of SIBO consists of managing any underlying diseases, correcting nutritional deficiencies, and use of antibiotics.”
BackgroundShah, A., Shanahan, E., Macdonald, G., Fletcher, L., Ghasemi, P., Morrison, M., Jones, M., & Holtmann, G. (2017) · Seminars in Liver Disease · doi:10.1055/s-0037-1608832 · Cited by 73
Gastrointestinal involvement in systemic sclerosis: An updated review
Nassar, M., Ghernautan, V., Nso, N., Nyabera, A., Castillo, F. J. C., Tu, W., Medina, L., Ciobanu, C., Alfishawy, M., Rizzo, V., et al. (2022) · Medicine · doi:10.1097/md.0000000000031780 · Cited by 85
“[65] The breath test’s 60% sensitivity and 80% specificity make it a favorable diagnostic option for SIBO assessment.[66,67] The majority of the SSc patients exhibit nutritional deficiency, malnutrition, and weight loss, requiring evidence-based management via nutritional support and hydration.”
BackgroundDiet and rosacea: the role of dietary change in the management of rosacea
Weiss, E., & Katta, R. (2017) · Dermatology Practical & Conceptual · doi:10.5826/dpc.0704a08 · Cited by 76
Small Intestinal Bacterial Overgrowth in Patients With Cirrhosis
Ghosh, G., & Jesudian, A. B. (2018) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2018.08.006 · Cited by 83
“There is inconsistency in the recommended load of glucose and/or lactulose to be administered and the time required for detecting fermentation to sufficiently perform breath testing.33 Debate also exists regarding the definition of a positive breath test for SIBO.”
BackgroundInfluentialThe small intestine: dining table of host–microbiota meetings
Delbaere, K., Roegiers, I. H., Bron, A., Durif, C., de Wiele, T. V., Blanquet‐Diot, S., & Marinelli, L. (2023) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuad022 · Cited by 80
Gudan, A., Jamioł-Milc, D., Hawryłkowicz, V., Skonieczna‐Żydecka, K., & Stachowska, E. (2022) · Nutrients · doi:10.3390/nu14245261 · Cited by 74
“The higher percentage of SIBO recorded when examining aspirates is probably due to the fact that it is the most accurate method of SIBO diagnostics, described as the gold standard [9,10].”
BackgroundMethodChonchubhair, H. N., Bashir, Y., Dobson, M., Ryan, B. M., Duggan, S. N., & Conlon, K. C. (2018) · Pancreatology · doi:10.1016/j.pan.2018.02.010 · Cited by 77
Zhao, J., Zheng, X., Chu, H., Zhao, J., Cong, Y., Fried, M., Fox, M., & Dai, N. (2014) · Neurogastroenterology & Motility · doi:10.1111/nmo.12331 · Cited by 67
Spiegel, B. M. R. (2011) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2011.02.030 · Cited by 67
Kashyap, P., Moayyedi, P., Quigley, E. M. M., Simrén, M., & Vanner, S. J. (2024) · Neurogastroenterology & Motility · doi:10.1111/nmo.14817 · Cited by 73
“…for SIBO, culture from jejunal aspirates, was also changed over time from 10 5 CFU/mL to 10 3 CFU/ml in the jejunum and then to 10 3 CFU/ml in the duodenum ( Figure 3 ) by authors simultaneously refuting the existence of any gold standard 27 and who have not vali - dated this new standard.”
BackgroundInfluentialWeinstock, L. B., & Walters, A. S. (2011) · Sleep Medicine · doi:10.1016/j.sleep.2011.03.007 · Cited by 69
Rosacea, Germs, and Bowels: A Review on Gastrointestinal Comorbidities and Gut–Skin Axis of Rosacea
Wang, F., & Chi, C. (2021) · Advances in Therapy · doi:10.1007/s12325-021-01624-x · Cited by 75
“SIBO is defined as small bowel aspirate of more than 10(5) colony-forming unit/ml as a gold standard although the diagnosis could be made by various tools [34].”
BackgroundMethodWedlake, L. J., Thomas, K., McGough, C., & Andreyev, J. N. (2008) · European Journal of Cancer · doi:10.1016/j.ejca.2008.07.018 · Cited by 66
Meyrat, P., Safroneeva, E., & Schoepfer, A. M. (2012) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12087 · Cited by 59
“following the ingestion of 10 g of the non-absorbable sugar lactulose dissolved in water.(9) According to the original definition of the positive LHBT, the rise of >20 ppm in hydrogen concentration occurring at least 15 min before a second rise in hydrogen concentration is”
MethodResultInfluentialSroka, N., Rydzewska–Rosołowska, A., Kakareko, K., Rosołowski, M., Głowińska, I., & Hryszko, T. (2022) · Nutrients · doi:10.3390/nu15010090 · Cited by 67
Specimen Collection, Transport, and Processing: Bacteriology
Baron, E. J., & Thomson, R. B. (2011) · Wiley eBooks · doi:10.1128/9781555816728.ch16 · Cited by 77
Suri, J. S., Kataria, R. D., Malik, Z. A., Parkman, H. P., & Schey, R. (2018) · Medicine · doi:10.1097/md.0000000000010554 · Cited by 60
“Due to the invasive nature of obtaining jejunal aspirate samples, hydrogen breath testing-with substrates such as glucose or lactulose (LBT)-has become awidely accepted alternative.([2]) Several studies have evaluated the use of LBT in diagnosing SIBO; however, the results have not been”
BackgroundRole of the duodenal microbiota in functional dyspepsia
Brown, G., Hoedt, E. C., Keely, S., Shah, A., Walker, M. M., Holtmann, G., & Talley, N. J. (2022) · Neurogastroenterology & Motility · doi:10.1111/nmo.14372 · Cited by 63
Small intestinal bacterial overgrowth in systemic sclerosis: a review of the literature
Polkowska-Pruszyńska, B., Gerkowicz, A., Szczepanik-Kułak, P., & Krasowska, D. (2018) · Archives of Dermatological Research · doi:10.1007/s00403-018-1874-0 · Cited by 57
Gudan, A., Kozłowska‐Petriczko, K., Wunsch, E., Bodnarczuk, T., & Stachowska, E. (2023) · Nutrients · doi:10.3390/nu15061323 · Cited by 62
“Usually associated with gastrointestinal symptoms such as bloating, excess gas, abdominal pain, diarrhea and weight loss [49].”
BackgroundDiagnosis and treatment of small intestinal bacterial overgrowth
Ponziani, F. R., Gerardi, V., & Gasbarrini, A. (2016) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.2016.1110017 · Cited by 52
“Nevertheless, oropharyngeal contamination is possible and many bacterial strains (80% compared with metagenomic methods) [19] are missed due to the impossibility to be cultured.[36] Therefore, although being considered as the ‘gold standard’ for SIBO diagnosis, culture-based analyses lack several important features th…”
BackgroundCangemi, D. J., Lacy, B. E., & Wise, J. L. (2020) · Digestive Diseases and Sciences · doi:10.1007/s10620-020-06484-z · Cited by 51
Does colectomy predispose to small intestinal bacterial (SIBO) and fungal overgrowth (SIFO)?
Rao, S. S. C., Tan, G., Abdulla, H., Yu, S., Larion, S., & Leelasinjaroen, P. (2018) · Clinical and Translational Gastroenterology · doi:10.1038/s41424-018-0011-x · Cited by 49
“Coagulase-negative staphylococci 0 (0) 1 (5)”
InfluentialSmall Intestinal Bacterial Overgrowth
Bushyhead, D. W., & Quigley, E. M. M. (2021) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2021.02.008 · Cited by 54
Antibiotics for the treatment of irritable bowel syndrome.
Basseri, R. J., Weitsman, S. R., Barlow, G. M., & Pimentel, M. (2011) · Europe PMC (PubMed Central) · Cited by 63
Self-citationRicci, J. E. R., Chebli, L. A., Ribeiro, T. C. D. R., Castro, A. C. S., Gaburri, P. D., Pace, F. H. D. L., Barbosa, K. V. B. D., Ferreira, L. E. V. V. D. C., Passos, M. D. C. F., Malaguti, C., et al. (2017) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000000803 · Cited by 46
Small intestinal bacterial overgrowth as a cause for irritable bowel syndrome: guilty or not guilty?
Aziz, I., Törnblom, H., & Simrén, M. (2017) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000348 · Cited by 45
Cresci, G., & Izzo, K. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-814330-8.00004-4 · Cited by 45
Celiac Disease and Other Causes of Duodenitis
Owen, D. R., & Owen, D. A. (2017) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2016-0608-ra · Cited by 44
“The diagnosis requires bacterial growth, chiefly of coliform bacteria, in excess of 10(3) organisms per milliliter of fluid.(60) Anti-tTG antibodies are not elevated in bacterial overgrowth syndrome.”
BackgroundPoon, D., Law, G. R., Major, G., & Andreyev, J. N. (2022) · Scientific Reports · doi:10.1038/s41598-022-05933-1 · Cited by 49
Lupan, O. I., Ababii, N., Mishra, A. K., Bodduluri, M. T., Magariu, N., Vahl, A., Krüger, H., Wagner, B., Faupel, F., Adelung, R., et al. (2021) · Sensors and Actuators A Physical · doi:10.1016/j.sna.2021.112804 · Cited by 43
Tuteja, A. K., Talley, N. J., Stoddard, G. J., & Verne, G. N. (2019) · Digestive Diseases and Sciences · doi:10.1007/s10620-018-5344-5 · Cited by 42
Irritable Bowel Syndrome and Small Intestinal Bacterial Overgrowth
Yamini, D., & Pimentel, M. (2010) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e3181ef3476 · Cited by 43
“Several conditions predispose individuals to SIBO, including motility disturbances (eg, diabetes and scleroderma), achlorhydria, anatomic obstruction (eg, bowel obstruction), and surgical alterations of the bowel reconstructions (eg, blind loops).16 Traditionally, SIBO has been defined as >105 colony-forming units/ mL…”
BackgroundInfluentialSelf-citationChang, M. S., Minaya, M. T., Cheng, J., Connor, B. A., Lewis, S. K., & Green, P. H. R. (2011) · Digestive Diseases and Sciences · doi:10.1007/s10620-011-1719-6 · Cited by 40
“lizing a ‘‘test, treat, and outcome’’ method that has been recommended by some groups [35].”
Metadata
- Authors
- Khoshini, R., Dai, S.-C., Lezcano, S., & Pimentel, M.
- Affiliations
- Harbor–UCLA Medical Center (US)
- Cedars-Sinai Medical Center (US)
- Corresponding author
- Pimentel, Mark
- ORCID
- Pimentel, Mark
- Venue
- Digestive Diseases and Sciences
- Published
- 2007-11-08
- Volume
- 53
- Issue
- 6
- Pages
- 1443-1454
- ISSN
- 0163-2116 (ISSN-L)
- 1573-2568
- OpenAlex
- W2115895723
- Cited by
- 323
- References
- 88
- Citations by year
- 2026: 13 · 2025: 19 · 2024: 19 · 2023: 20 · 2022: 22 · 2021: 23 · 2020: 27 · 2019: 18 · 2018: 18 · 2017: 18 · 2016: 15 · 2015: 21 · 2014: 19 · 2013: 12 · 2012: 9
- FWCI
- 1.75
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Digestive Diseases and Sciences (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Beatrice and Samuel A. Seaver Foundation
- Topics
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal Bleeding Diagnosis and Treatment
- Keywords
- small intestinal bacterial overgrowth, SIBO diagnosis, diagnostic test validity, bacterial culture, breath test, gold standard, diagnostic accuracy
- MeSH terms
- Bacteria, Bacterial Infections, Breath Tests, Diagnostic Techniques, Digestive System, Humans, Intestine, Small, Colony Count, Microbial, Cell Culture Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.